SCPX Scorpius Holdings: Enterprise Value-to-Revenue Multiple

Public company logo of Scorpius Holdings Inc. (SCPX)

The EV/Sales ratio reflects the capital inflow dynamics into the Scorpius Holdings, Inc. (SCPX) CDMO ecosystem, where the current status is . The business model relies on the long-term lock-in of biopharmaceutical developers. Strict GMP certifications and unique sterile laboratories provide asset protection. High demand from biotech startups for flexible capacity ensures the company's resilience in the face of market saturation.

Scorpius Holdings Inc. - SCPX Enterprise Value-to-Revenue Ratio (period 07/04/2022 - 11/20/2026)

Financial and market metric breakdowns for Scorpius Holdings Inc. (SCPX)

- market value and analyst target forecast:
- money and cash flow information:
Initial company analysis:SCPX (Scorpius Holdings)
Original product of Scorpius Holdings

Biotech startups' demand for flexible CDMO sector capacity provides Scorpius Holdings, Inc. (SCPX) with a steady order flow, which is reflected in the company's EV/Sales trend. This ratio compares the total enterprise value (market capitalization and net debt) to annual revenue, allowing for a real-time assessment of the value of each dollar of revenue regardless of leverage and confirming the asset's fundamental stability.